N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide

C128H149N19O11 — CID 158834931

IUPACN-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide
SMILESCC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NC(C(N)=O)c2ccc(O)cc2)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NCCc2ccc(O)cc2)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1
InChIInChI=1S/C33H39N5O3.C32H37N5O3.C32H38N4O2.C31H35N5O3/c1-33(2,3)24-14-16-25(17-15-24)38-26(22-29(37-38)28-10-7-8-20-35-28)9-5-4-6-11-31(40)36-30(32(34)41)21-23-12-18-27(39)19-13-23;1-32(2,3)23-14-16-24(17-15-23)37-25(21-28(36-37)27-10-7-8-20-34-27)9-5-4-6-11-29(39)35-30(31(33)40)22-12-18-26(38)19-13-22;1-32(2,3)25-14-16-26(17-15-25)36-27(23-30(35-36)29-10-7-8-21-33-29)9-5-4-6-11-31(38)34-22-20-24-12-18-28(37)19-13-24;1-21(2)23-12-14-24(15-13-23)36-25(20-28(35-36)27-8-5-6-18-33-27)7-3-4-9-30(38)34-29(31(32)39)19-22-10-16-26(37)17-11-22/h7-8,10,12-20,22,30,39H,4-6,9,11,21H2,1-3H3,(H2,34,41)(H,36,40);7-8,10,12-21,30,38H,4-6,9,11H2,1-3H3,(H2,33,40)(H,35,39);7-8,10,12-19,21,23,37H,4-6,9,11,20,22H2,1-3H3,(H,34,38);5-6,8,10-18,20-21,29,37H,3-4,7,9,19H2,1-2H3,(H2,32,39)(H,34,38)/t30-;;;29-/m1..1/s1
InChIKeyIXMZLCUPCGQYRG-UAOHFMMQSA-N
MW2129.72 g/mol
LogP21.72
Rot. Bonds46

About N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide

N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide (PubChem CID 158834931) has the molecular formula C128H149N19O11 and a molecular weight of 2129.72 g/mol. Its IUPAC name is N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide.

Molecular Properties

Compound NameN-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide
PubChem CID158834931
Molecular FormulaC128H149N19O11
Molecular Weight2129.72 g/mol
Exact Mass2128.17
IUPAC NameN-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide
SMILESCC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NC(C(N)=O)c2ccc(O)cc2)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NCCc2ccc(O)cc2)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1
InChIInChI=1S/C33H39N5O3.C32H37N5O3.C32H38N4O2.C31H35N5O3/c1-33(2,3)24-14-16-25(17-15-24)38-26(22-29(37-38)28-10-7-8-20-35-28)9-5-4-6-11-31(40)36-30(32(34)41)21-23-12-18-27(39)19-13-23;1-32(2,3)23-14-16-24(17-15-23)37-25(21-28(36-37)27-10-7-8-20-34-27)9-5-4-6-11-29(39)35-30(31(33)40)22-12-18-26(38)19-13-22;1-32(2,3)25-14-16-26(17-15-25)36-27(23-30(35-36)29-10-7-8-21-33-29)9-5-4-6-11-31(38)34-22-20-24-12-18-28(37)19-13-24;1-21(2)23-12-14-24(15-13-23)36-25(20-28(35-36)27-8-5-6-18-33-27)7-3-4-9-30(38)34-29(31(32)39)19-22-10-16-26(37)17-11-22/h7-8,10,12-20,22,30,39H,4-6,9,11,21H2,1-3H3,(H2,34,41)(H,36,40);7-8,10,12-21,30,38H,4-6,9,11H2,1-3H3,(H2,33,40)(H,35,39);7-8,10,12-19,21,23,37H,4-6,9,11,20,22H2,1-3H3,(H,34,38);5-6,8,10-18,20-21,29,37H,3-4,7,9,19H2,1-2H3,(H2,32,39)(H,34,38)/t30-;;;29-/m1..1/s1
InChIKeyIXMZLCUPCGQYRG-UAOHFMMQSA-N
XLogP21.72
TPSA449.43 Ų
H-Bond Donors11
H-Bond Acceptors23
Rotatable Bonds46
Heavy Atoms158
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002129.72
LogP ≤ 521.72
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide?
The IUPAC name of N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide (CID 158834931) is N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide.
What is the SMILES notation for N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide?
The canonical SMILES for N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide is CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NC(C(N)=O)c2ccc(O)cc2)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NCCc2ccc(O)cc2)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.
What is the InChIKey of N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide?
The InChIKey is IXMZLCUPCGQYRG-UAOHFMMQSA-N. The full InChI is InChI=1S/C33H39N5O3.C32H37N5O3.C32H38N4O2.C31H35N5O3/c1-33(2,3)24-14-16-25(17-15-24)38-26(22-29(37-38)28-10-7-8-20-35-28)9-5-4-6-11-31(40)36-30(32(34)41)21-23-12-18-27(39)19-13-23;1-32(2,3)23-14-16-24(17-15-23)37-25(21-28(36-37)27-10-7-8-20-34-27)9-5-4-6-11-29(39)35-30(31(33)40)22-12-18-26(38)19-13-22;1-32(2,3)25-14-16-26(17-15-25)36-27(23-30(35-36)29-10-7-8-21-33-29)9-5-4-6-11-31(38)34-22-20-24-12-18-28(37)19-13-24;1-21(2)23-12-14-24(15-13-23)36-25(20-28(35-36)27-8-5-6-18-33-27)7-3-4-9-30(38)34-29(31(32)39)19-22-10-16-26(37)17-11-22/h7-8,10,12-20,22,30,39H,4-6,9,11,21H2,1-3H3,(H2,34,41)(H,36,40);7-8,10,12-21,30,38H,4-6,9,11H2,1-3H3,(H2,33,40)(H,35,39);7-8,10,12-19,21,23,37H,4-6,9,11,20,22H2,1-3H3,(H,34,38);5-6,8,10-18,20-21,29,37H,3-4,7,9,19H2,1-2H3,(H2,32,39)(H,34,38)/t30-;;;29-/m1..1/s1.
What are the key properties of N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide?
N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide has a molecular weight of 2129.72 g/mol, XLogP of 21.72, 46 rotatable bonds, 11 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-amino-1-(4-hydroxyphenyl)-2-oxoethyl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;6-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide is sourced from PubChem (CID 158834931), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).